Hims & Hers Health Inc (NYSE: HIMS) is a telehealth company that connects consumers with licensed healthcare providers and dispenses prescription and over-the-counter treatments through a direct-to-consumer digital platform. Revenue is generated primarily through subscription-based and one-time product purchases covering treatments in sexual health, hair loss, mental health, skincare, and weight management. The company's Class A common stock trades on the New York Stock Exchange, and as of June 30, 2025, the aggregate market value of voting stock held by non-affiliates was approximately calculated at $49.85 per share. The filing covers the fiscal year ended as reported in the 10-K filed February 23, 2026 (accession 000177375126000022). Two share classes are outstanding: Class A and Class V common stock.

Revenue model

The excerpts provided do not contain sufficient detail to characterize specific revenue segment splits, subscription versus transaction ratios, or disclosed unit economics. Based solely on the available filing excerpts, a precise revenue model breakdown cannot be stated.

Products and services

The filing excerpts do not enumerate specific products or branded treatments with supporting detail. No product names, SKU counts, or service category revenue figures are present in the provided excerpts.

Customers and end markets

The filing excerpts do not disclose customer counts, subscriber counts, or end market revenue breakdowns. No customer concentration data is present in the provided excerpts.

Value-chain role

Direct-to-consumer telehealth platform connecting patients with licensed providers and fulfilling prescription and OTC treatments, based on filing context.

Geographic exposure

Not supported by the provided filing excerpts.

Source: SEC 10-K, filed 2026-02-23

Industry: Services-Offices & Clinics of Doctors of Medicine Peers: 23ANDME HOLDING CO. Cross Country Healthcare Inc CVS Health Corp DocGo Inc P3 Health Partners Inc Fulgent Genetics Inc National Research Corp RadNet Inc